Regulon: R-908
Regulons
are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.
Regulon Summary
Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio
, its Regulator
, the Transcriptional Program
that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.
Genes | Cox Hazard Ratio | Regulators | Causal Flows | Transcriptional Programs | Hallmarks |
---|---|---|---|---|---|
25 | 1.09965 | 1 | 0 | Pr-143 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Regulon Genes
List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator
of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.
Regulon Drugs
Name | Approved Symbol | Type | Action Type | Mechanism of Action | Max Trial Phase | Max GBM Phase |
---|---|---|---|---|---|---|
RUXOLITINIB | JAK1 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 4 | 1 |
PACRITINIB | FLT3 | Small molecule | INHIBITOR | Tyrosine-protein kinase receptor FLT3 inhibitor | 3 | 0 |
IZENCITINIB | JAK1 | Small molecule | INHIBITOR | Janus Kinase (JAK) inhibitor | 2 | 0 |
TOFACITINIB | JAK1 | Small molecule | INHIBITOR | Janus Kinase (JAK) inhibitor | 4 | 0 |
GANDOTINIB | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 2 | 0 |
DASATINIB | ABL1 | Small molecule | INHIBITOR | Platelet-derived growth factor receptor beta inhibitor | 4 | 2 |
RUXOLITINIB PHOSPHATE | JAK1 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 4 | 0 |
PEFICITINIB | JAK1 | Small molecule | INHIBITOR | Janus Kinase (JAK) inhibitor | 3 | 0 |
DIPYRIDAMOLE | SLC29A1 | Small molecule | INHIBITOR | 3',5'-cyclic phosphodiesterase inhibitor | 4 | 0 |
FORIGERIMOD | HSPA8 | Protein | INHIBITOR | Heat shock cognate 71 kDa protein inhibitor | 3 | 0 |
LESTAURTINIB | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 3 | 0 |
AC-430 | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 1 | 0 |
BOSUTINIB | ABL1 | Small molecule | INHIBITOR | Bcr/Abl fusion protein | 4 | 2 |
BAFETINIB | LYN | Small molecule | INHIBITOR | Tyrosine-protein kinase ABL inhibitor | 2 | 0 |
MOMELOTINIB | JAK1 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 3 | 0 |
NS-018 | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 2 | 0 |
BARICITINIB | JAK1 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 4 | 0 |
ILORASERTIB | PDGFRB | Small molecule | INHIBITOR | Serine/threonine-protein kinase Aurora inhibitor | 2 | 0 |
BMS-911543 | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 2 | 0 |
JNJ-26483327 | ERBB2 | Small molecule | INHIBITOR | Tyrosine-protein kinase FYN inhibitor | 1 | 0 |
UPADACITINIB | JAK1 | Small molecule | INHIBITOR | Janus Kinase (JAK) inhibitor | 4 | 0 |
FEDRATINIB HYDROCHLORIDE | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 4 | 0 |
XL-228 | ABL1 | Small molecule | INHIBITOR | Tyrosine-protein kinase ABL inhibitor | 1 | 0 |
ZOTIRACICLIB | CDK9 | Small molecule | INHIBITOR | Cyclin-dependent kinase 9 inhibitor | 1 | 1 |
TOFACITINIB CITRATE | JAK1 | Small molecule | INHIBITOR | Janus Kinase (JAK) inhibitor | 4 | 0 |
FORIGERIMOD ACETATE | HSPA8 | Protein | INHIBITOR | Heat shock cognate 71 kDa protein inhibitor | 3 | 0 |
GUSACITINIB | SYK | Small molecule | INHIBITOR | Janus Kinase (JAK) inhibitor | 2 | 0 |
TOLIMIDONE | LYN | Small molecule | POSITIVE ALLOSTERIC MODULATOR | Tyrosine-protein kinase Lyn positive allosteric modulator | 2 | 0 |
TG100-801 | EPHB4 | Small molecule | INHIBITOR | SRC inhibitor | 2 | 0 |
XL-019 | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 1 | 0 |
AZD-1480 | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 2 | 0 |
DELGOCITINIB | JAK1 | Small molecule | INHIBITOR | Janus Kinase (JAK) inhibitor | 3 | 0 |
AT-9283 | AURKB | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK3 inhibitor | 2 | 0 |
FEDRATINIB | JAK2 | Small molecule | INHIBITOR | Tyrosine-protein kinase JAK2 inhibitor | 4 | 0 |
ENMD-981693 | PDGFRB | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 2 | 0 |
Causal Flows
Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation
may causally activates or deactivates a downstream regulator
which then might up- or down-regulates a regulon
that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows for Regulon R-908
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|